Vaccinex

$2.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.11 (-3.90%) Today

+$0.09 (+3.32%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Vaccinex and other stocks, options, and ETFs commission-free!

About VCNX

Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the development of targeted bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases and autoimmune disorders.

CEO

Maurice Zauderer

Employees

Headquarters

Rochester, New York

Founded

1997

Market Cap

79.26M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

355.92K

High Today

$2.86

Low Today

$2.71

Open Price

$2.78

Volume

256.82K

52 Week High

$9.56

52 Week Low

$1.63

VCNX Earnings

-$0.58

-$0.39

-$0.19

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 13, Pre-Market